Netflix & Shahid Launch Middle East's 1st Joint Subscription
This ground‑breaking bundle, launched initially in Saudi Arabia, delivers Netflix's full global library—series, films, documentaries, live events, gaming—alongside Shahid's rich Arabic-language dramas, films, documentaries, and MBC's linear TV channels.
Subscribers can now enjoy this hybrid package through MBCNOW, the entertainment hub launched by MBC earlier in 2025. Shahid continues as a standalone service, but the Netflix‑Shahid bundle is exclusively offered via MBCNOW.
Netflix has never before offered a region-specific bundle with a local OTT service like Shahid. The deal sets a new precedent in cross-platform partnerships.
Viewers get the best of both worlds—Netflix's global content (e.g., Squid Game) and Shahid's award-winning Arabic titles and live TV channels—all accessible under one roof.
Consumers save over 21% compared to subscribing separately to both services. The joint subscription will be immediately available in Saudi Arabia at major retailers and online platforms.
Rollout across the GCC and wider MENA region is slated for after the summer, with specific launch dates pending.
MBCNOW was launched in February 2025, aiming to converge MBC's broadcast channels, Shahid, and now Netflix into one entertainment ecosystem.
This milestone marks a pivotal moment in MENA's streaming landscape—merging global reach with regional storytelling in one accessible, cost-effective bundle.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
35 minutes ago
- Zawya
Mideast Stocks: Most Gulf markets fall on weak earnings, US economic worries
Most stock markets in the Gulf ended lower on Sunday hit by lacklustre earnings, while a cooling U.S. labor market clouded the Federal Reserve's policy outlook as investors scrutinized recent U.S. tariff decisions. U.S. President Donald Trump signed an executive order on Thursday imposing tariffs ranging from 10% to 41% on U.S. imports from dozens of countries that failed to reach trade deals with Washington by his August 1 deadline. Saudi Arabia's benchmark index dropped 0.8%, hit by a 1.2% decline by oil behemoth Saudi Aramco ahead of its earnings announcement on Tuesday. Jabal Omar Development slid 5.4%, after posting a second-quarter loss. The developer - which runs the Jabal Omar complex of hotels and property near Mecca's Grand Mosque - was hit by reduced hotel revenues and a 106 million riyal ($28.26 million) property impairment charge, which lowered gross profit. Among other losers, Saudi Basic Industries Corp - 70% owned by Saudi Aramco - retreated 1.2%, after reporting a second-quarter loss. The chemical firm attributed its losses to 3.78 billion riyals in impairment charges and provisions related to a cracker closure in the UK in line with a portfolio review to reduce costs and improve profitability. Oil prices - a catalyst for the Gulf's financial markets - fell $2 a barrel on Friday due to jitters over a potential production hike by OPEC and its allies, while a weaker-than-expected U.S. jobs report fed worries about demand. Eight OPEC+ countries meeting on Sunday have agreed to raise oil output in September by 548,000 barrels per day, Reuters reported citing two OPEC+ sources while the meeting was still under way. Elsewhere, Saudi Aramco Base Oil Co plunged 10% - its biggest intraday fall since its listing in December 2022 - following an 18% drop in quarterly profit. In Qatar, the index fell 0.8%, with Qatar Islamic Bank losing 1.8%. Outside the Gulf, Egypt's blue-chip index added 0.2%, helped by a 3.2% rise in tobacco monopoly Eastern Company . SAUDI ARABIA fell 0.8% to 10,833 QATAR dropped 0.8% to 11,168 EGYPT up 0.2% to 34,272 BAHRAIN lost 0.2% to 1,952 OMAN down 0.2% at 4,770 KUWAIT eased 0.4% to 9,294 ($1 = 3.7511 riyals) (Reporting by Ateeq Shariff in Bengaluru; Editing by Joe Bavier)
Zawya
35 minutes ago
- Zawya
Saudi chemical maker SABIC reports another surprise loss in Q2
DUBAI: Saudi chemicals company SABIC reported another surprise quarterly loss on Sunday, after deciding to shut a cracker in Britain amid a restructuring of its business during an industry slowdown. SABIC reported a net loss of 4.07 billion riyals ($1.09 billion) for the three months to June 30, missing analysts' expectations of a profit of 504 million riyals, LSEG data showed. Shares declined 1.6% at the open to 53.8 riyals a piece. SABIC, 70% owned by oil major Saudi Aramco, has posted three consecutive losses in quarterly earnings as the chemicals industry grapples with weak demand that has weighed on sales. The company attributed the latest loss mainly to a 3.78 billion riyals impairment related to the cracker closure, as well as impairment charges for its investment in Swiss speciality chemicals maker Clariant due to its share price decline. In another filing on Sunday, the company proposed a dividend of 1.5 riyals per share for the first half of the year. SABIC shares are down almost 19% this year on the Saudi exchange. The company said last month it was studying strategic options for its National Industrial Gases Company, including an initial public offering, amid a broad review of its business. SABIC said in a statement the move was in line with its portfolio optimisation and core business focus strategy, adding that an IPO of GAS would be aimed at improving the group's "financial position and the value added for shareholders". ($1 = 3.7511 riyals) (Reporting by Hadeel Al Sayegh; Editing by Toby Chopra and William Mallard)
Zawya
35 minutes ago
- Zawya
Middle East Healthcare announces substantial revenue and net profit growth for the Q2 of 2025
Jeddah, KSA: 'Middle East Healthcare Company' (Saudi German Health), which operates a network of hospitals and polyclinics in seven major cities across the Kingdom of Saudi Arabia (Jeddah, Asir, Riyadh, Medinah, Hail, Dammam, and Mekkah), announced its preliminary financial results for the second quarter ending 30 June 2025, achieving a net profit of SAR 64 million, implying a 47% year-on-year growth, excluding a SAR 20 million gain on the sale of non-recurring land in the same period. This performance reflects a significant improvement in operational efficiency and a reduction in financing costs due to an improved debt structure. The reported net profit for the second quarter of this year reached SAR 64 million, compared to SAR 63 million in the same period last year (including non-recurring gains from the sale of land). Net profit growth was driven by an 11% increase in revenues to SAR 791 million, driven by increased inpatient admissions, increased outpatient visits, and a growing number of surgical procedures. This growth was also fueled by the SAR 47 million contract to operate the Mina II Emergency Hospital during the 2025 Hajj season, along with the expansion of the Dammam Hospital's bed capacity from 150 to 300 beds. The company recorded a 10% growth in gross profit to SAR 308 million, while maintaining a stable gross profit margin of 38.9%. For the first half of 2025, the company achieved a 109% jump in net profit to SAR 224 million, while revenues grew by 9% to SAR 1.525 billion. This performance is attributed to the growth of operations in the Makkah, Dammam, and Hail regions, the enhancement of competitiveness by its hospitals in Asir and Riyadh receiving the prestigious Magnet accreditation for nursing excellence, and the ongoing implementation of the SAR 400 million expansion project at Jeddah Hospital, which will increase its capacity by more than 190 beds upon completion. The company's management confirmed that these results reflect the strength of its operating model and its ability to achieve sustainable growth in a highly competitive market. It noted that the company continues to invest in geographic expansion and operational efficiency, while remaining committed to providing world-class healthcare. The general assembly approved the board of directors' recommendation to distribute a cash dividends of SAR 0.50 per share (equivalent to 5% of the nominal value) for the fiscal year 2024. The management added that the company plans to continue its expansion and investment in subspecialties, with a focus on improving the patient experience and enhancing operational efficiency. Notably, the Saudi German Health's vision revolves around providing integrated medical solutions through its extensive network of hospitals and specialized centers, including diagnostic services (laboratories and radiology) and treatment (health rehabilitation and specialized clinics), with a focus on investing in medical infrastructure through land acquisition and the development of healthcare facilities. Investors can contact the Investment Relations team at president4@ for more details.
